- Home
- SXC vs VOR Comparison
SXC vs VOR Comparison
Compare SXC & VOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SXC | VOR |
|---|---|---|
| Founded | 1960 | 2015 |
| Country | United States | United States |
| Employees | 848 | N/A |
| Industry | Steel/Iron Ore | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 516.5M | 562.6M |
| IPO Year | 2011 | 2021 |
Fundamental Metrics
Financial Performance| Metric | SXC | VOR |
|---|---|---|
| Price | $6.24 | $14.55 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 1 | 10 |
| Target Price | $9.00 | ★ $64.78 |
| AVG Volume (30 Days) | ★ 1.6M | 676.1K |
| Earning Date | 05-20-2026 | 01-01-0001 |
| Dividend Yield | ★ 7.51% | N/A |
| EPS Growth | N/A | ★ 2.86 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $1,600,300,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $4.74 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 10.30 | N/A |
| 52 Week Low | $5.52 | $0.13 |
| 52 Week High | $9.82 | $49.95 |
Technical Indicators
Market Signals| Indicator | SXC | VOR |
|---|---|---|
| Relative Strength Index (RSI) | 39.65 | 50.45 |
| Support Level | $5.52 | $11.27 |
| Resistance Level | $6.97 | $14.73 |
| Average True Range (ATR) | 0.36 | 1.15 |
| MACD | -0.03 | 0.07 |
| Stochastic Oscillator | 28.60 | 41.43 |
Price Performance
Historical ComparisonAbout SXC SunCoke Energy Inc.
SunCoke Energy Inc operates as an independent producer of coke in the Americas. Its coke is mainly used as a principal raw material in the blast furnace steelmaking process as well as in the foundry production of casted iron. The company operates through two segments: Domestic Coke and Industrial Services. It offers metallurgical and thermal coal. The company also provides handling and/or mixing services to steel, coke, electric utility, coal-producing, and other manufacturing-based customers. The majority of revenue is derived from the Domestic Coke segment.
About VOR Vor Biopharma Inc.
Vor Biopharma Inc is a clinical stage cell therapy company. It combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological malignancies. The company's products include VCAR33, Tremcel and Myelodysplastic Syndrome, Trem-cel+VCAR33 Treatment System, VADC45, CD123, CLL1, EMR2.